Overview

Chemosensitization With Plerixafor Plus G-CSF in Acute Myeloid Leukemia

Status:
Completed
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
This study is designed to test the combination of Plerixafor with G-CSF for chemosensitization in patients with relapsed or refractory AML.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Washington University School of Medicine
Treatments:
Cytarabine
Etoposide
Etoposide phosphate
JM 3100
Lenograstim
Mitoxantrone
Plerixafor